EHD3 and colorectal carcinoma: For instance, a prospective analysis of the influence of EHD3 hypermethylation and MSI-H on CRC drug response with an adequate sample size may help in combining EHD3 methylation level with MSI status to develop a strong indicator for CRC treatment.